Devicor Medical Products, Inc. Overview
Company Headquarters: Ohio, US
Founded: 1995
Workforce: ~ 400
Company Working: Devicor Medical Products, Inc. develops and distributes medical products and technologies. The company offers the Mammotome Breast Biopsy System, Mammotome Revolve, the tetherless Mammotome Elite, Sentinel Node Biopsy systems, Neoprobe Gamma Detection System (GDS), Mammotome MammoTestTM stereotactic biopsy table, as well as a wide range of tissue markers used in the diagnostic sampling and management of breast disease. Devicor, the market leader worldwide, is dedicated to developing technologies that will assist clinicians in precisely diagnosing breast diseases, such as breast cancer, using minimally invasive techniques. The company's distribution network provides services to more than 50 countries. Furthermore, it has operations in North America, Europe, and the Asia pacific.
Strategy
Devicor Medical Products aims to achieve growth by expanding its product portfolio and geographic reach through both organic growth and acquisitions. The company is focused on expanding its market share in emerging markets with increasing healthcare needs, while also developing new products and technologies that can improve patient outcomes and reduce healthcare costs. Devicor Medical Products is investing in research and development to develop new breast biopsy and breast cancer treatment products, and is also pursuing strategic partnerships and collaborations to leverage complementary capabilities and expand its market reach. The company is committed to providing high-quality products and services to healthcare providers, and to improving the accuracy and efficiency of breast cancer diagnosis and treatment through innovation and education.



